Table of Contents 1 Rheumatoid Arthritis (RA) Drugs Market Overview 1.1 Product Overview and Scope of Rheumatoid Arthritis (RA) Drugs 1.2 Classification of Rheumatoid Arthritis (RA) Drugs by Types 1.2.1 Global Rheumatoid Arthritis (RA) Drugs Revenue Comparison by Types (2017-2023) 1.2.2 Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Types in 2017 1.2.3 Oral 1.2.4 Injection 1.2.5 External 1.3 Global Rheumatoid Arthritis (RA) Drugs Market by Application 1.3.1 Global Rheumatoid Arthritis (RA) Drugs Market Size and Market Share Comparison by Applications (2013-2023) 1.3.2 Medical Care 1.3.3 Personal Care 1.4 Global Rheumatoid Arthritis (RA) Drugs Market by Regions 1.4.1 Global Rheumatoid Arthritis (RA) Drugs Market Size (Million USD) Comparison by Regions (2013-2023) 1.4.1 North America (USA, Canada and Mexico) Rheumatoid Arthritis (RA) Drugs Status and Prospect (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Rheumatoid Arthritis (RA) Drugs Status and Prospect (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Rheumatoid Arthritis (RA) Drugs Status and Prospect (2013-2023) 1.4.4 South America (Brazil, Argentina, Colombia) Rheumatoid Arthritis (RA) Drugs Status and Prospect (2013-2023) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Rheumatoid Arthritis (RA) Drugs Status and Prospect (2013-2023) 1.5 Global Market Size of Rheumatoid Arthritis (RA) Drugs (2013-2023) 2 Manufacturers Profiles 2.1 AbbVie 2.1.1 Business Overview 2.1.2 Rheumatoid Arthritis (RA) Drugs Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 AbbVie Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017) 2.2 Roche 2.2.1 Business Overview 2.2.2 Rheumatoid Arthritis (RA) Drugs Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Roche Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017) 2.3 Johnson & Johnson 2.3.1 Business Overview 2.3.2 Rheumatoid Arthritis (RA) Drugs Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017) 2.4 Amgen, Inc. 2.4.1 Business Overview 2.4.2 Rheumatoid Arthritis (RA) Drugs Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017) 2.5 Pfizer 2.5.1 Business Overview 2.5.2 Rheumatoid Arthritis (RA) Drugs Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Pfizer Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017) 2.6 Merck 2.6.1 Business Overview 2.6.2 Rheumatoid Arthritis (RA) Drugs Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Merck Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017) 2.7 Bristol-Myers Squibb 2.7.1 Business Overview 2.7.2 Rheumatoid Arthritis (RA) Drugs Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017) 2.8 UCB 2.8.1 Business Overview 2.8.2 Rheumatoid Arthritis (RA) Drugs Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 UCB Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017) 2.9 GlaxoSmithKline 2.9.1 Business Overview 2.9.2 Rheumatoid Arthritis (RA) Drugs Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 GlaxoSmithKline Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017) 2.10 Sanofi 2.10.1 Business Overview 2.10.2 Rheumatoid Arthritis (RA) Drugs Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Sanofi Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017) 2.11 Abbott Laboratories 2.11.1 Business Overview 2.11.2 Rheumatoid Arthritis (RA) Drugs Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017) 2.12 Teva Pharmaceutical 2.12.1 Business Overview 2.12.2 Rheumatoid Arthritis (RA) Drugs Type and Applications 2.12.2.1 Product A 2.12.2.2 Product B 2.12.3 Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017) 3 Global Rheumatoid Arthritis (RA) Drugs Market Competition, by Players 3.1 Global Rheumatoid Arthritis (RA) Drugs Revenue and Share by Players (2013-2018) 3.2 Market Concentration Rate 3.2.1 Top 5 Rheumatoid Arthritis (RA) Drugs Players Market Share 3.2.2 Top 10 Rheumatoid Arthritis (RA) Drugs Players Market Share 3.3 Market Competition Trend 4 Global Rheumatoid Arthritis (RA) Drugs Market Size by Regions 4.1 Global Rheumatoid Arthritis (RA) Drugs Revenue and Market Share by Regions 4.2 North America Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) 4.3 Europe Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) 4.4 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) 4.5 South America Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) 4.6 Middle East and Africa Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) 5 North America Rheumatoid Arthritis (RA) Drugs Revenue by Countries 5.1 North America Rheumatoid Arthritis (RA) Drugs Revenue by Countries (2013-2018) 5.2 USA Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) 5.3 Canada Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) 5.4 Mexico Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) 6 Europe Rheumatoid Arthritis (RA) Drugs Revenue by Countries 6.1 Europe Rheumatoid Arthritis (RA) Drugs Revenue by Countries (2013-2018) 6.2 Germany Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) 6.3 UK Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) 6.4 France Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) 6.5 Russia Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) 6.6 Italy Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) 7 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue by Countries 7.1 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue by Countries (2013-2018) 7.2 China Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) 7.3 Japan Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) 7.4 Korea Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) 7.5 India Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) 7.6 Southeast Asia Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) 8 South America Rheumatoid Arthritis (RA) Drugs Revenue by Countries 8.1 South America Rheumatoid Arthritis (RA) Drugs Revenue by Countries (2013-2018) 8.2 Brazil Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) 8.3 Argentina Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) 8.4 Colombia Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) 9 Middle East and Africa Revenue Rheumatoid Arthritis (RA) Drugs by Countries 9.1 Middle East and Africa Rheumatoid Arthritis (RA) Drugs Revenue by Countries (2013-2018) 9.2 Saudi Arabia Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) 9.3 UAE Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) 9.4 Egypt Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) 9.5 Nigeria Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) 9.6 South Africa Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) 10 Global Rheumatoid Arthritis (RA) Drugs Market Segment by Type 10.1 Global Rheumatoid Arthritis (RA) Drugs Revenue and Market Share by Type (2013-2018) 10.2 Global Rheumatoid Arthritis (RA) Drugs Market Forecast by Type (2018-2023) 10.3 Oral Revenue Growth Rate (2013-2023) 10.4 Injection Revenue Growth Rate (2013-2023) 10.5 External Revenue Growth Rate (2013-2023) 11 Global Rheumatoid Arthritis (RA) Drugs Market Segment by Application 11.1 Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Application (2013-2018) 11.2 Rheumatoid Arthritis (RA) Drugs Market Forecast by Application (2018-2023) 11.3 Medical Care Revenue Growth (2013-2018) 11.4 Personal Care Revenue Growth (2013-2018) 12 Global Rheumatoid Arthritis (RA) Drugs Market Size Forecast (2018-2023) 12.1 Global Rheumatoid Arthritis (RA) Drugs Market Size Forecast (2018-2023) 12.2 Global Rheumatoid Arthritis (RA) Drugs Market Forecast by Regions (2018-2023) 12.3 North America Rheumatoid Arthritis (RA) Drugs Revenue Market Forecast (2018-2023) 12.4 Europe Rheumatoid Arthritis (RA) Drugs Revenue Market Forecast (2018-2023) 12.5 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue Market Forecast (2018-2023) 12.6 South America Rheumatoid Arthritis (RA) Drugs Revenue Market Forecast (2018-2023) 12.7 Middle East and Africa Rheumatoid Arthritis (RA) Drugs Revenue Market Forecast (2018-2023) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

List of Tables and Figures Figure Rheumatoid Arthritis (RA) Drugs Picture Table Product Specifications of Rheumatoid Arthritis (RA) Drugs Table Global Rheumatoid Arthritis (RA) Drugs and Revenue (Million USD) Market Split by Product Type Figure Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Types in 2017 Figure Oral Picture Figure Injection Picture Figure External Picture Table Global Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) by Application (2013-2023) Figure Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Applications in 2017 Figure Medical Care Picture Figure Personal Care Picture Table Global Market Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) Comparison by Regions 2013-2023 Figure North America Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) and Growth Rate (2013-2023) Figure Europe Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) and Growth Rate (2013-2023) Figure Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) and Growth Rate (2013-2023) Figure South America Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) and Growth Rate (2013-2023) Figure Middle East and Africa Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) and Growth Rate (2013-2023) Figure Global Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) and Growth Rate (2013-2023) Table AbbVie Basic Information, Manufacturing Base and Competitors Table AbbVie Rheumatoid Arthritis (RA) Drugs Type and Applications Table AbbVie Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017) Table Roche Basic Information, Manufacturing Base and Competitors Table Roche Rheumatoid Arthritis (RA) Drugs Type and Applications Table Roche Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017) Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors Table Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Type and Applications Table Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017) Table Amgen, Inc. Basic Information, Manufacturing Base and Competitors Table Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Type and Applications Table Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017) Table Pfizer Basic Information, Manufacturing Base and Competitors Table Pfizer Rheumatoid Arthritis (RA) Drugs Type and Applications Table Pfizer Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017) Table Merck Basic Information, Manufacturing Base and Competitors Table Merck Rheumatoid Arthritis (RA) Drugs Type and Applications Table Merck Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017) Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors Table Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Type and Applications Table Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017) Table UCB Basic Information, Manufacturing Base and Competitors Table UCB Rheumatoid Arthritis (RA) Drugs Type and Applications Table UCB Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017) Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors Table GlaxoSmithKline Rheumatoid Arthritis (RA) Drugs Type and Applications Table GlaxoSmithKline Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017) Table Sanofi Basic Information, Manufacturing Base and Competitors Table Sanofi Rheumatoid Arthritis (RA) Drugs Type and Applications Table Sanofi Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017) Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors Table Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Type and Applications Table Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017) Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors Table Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Type and Applications Table Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2016-2017) Table Global Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) by Players (2013-2018) Table Global Rheumatoid Arthritis (RA) Drugs Revenue Share by Players (2013-2018) Figure Global Rheumatoid Arthritis (RA) Drugs Revenue Share by Players in 2016 Figure Global Rheumatoid Arthritis (RA) Drugs Revenue Share by Players in 2017 Figure Global Top 5 Players Rheumatoid Arthritis (RA) Drugs Revenue Market Share in 2017 Figure Global Top 10 Players Rheumatoid Arthritis (RA) Drugs Revenue Market Share in 2017 Figure Global Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) and Growth Rate (%) (2013-2018) Table Global Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) by Regions (2013-2018) Table Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Regions (2013-2018) Figure Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Regions (2013-2018) Figure Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Regions in 2017 Figure North America Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) Figure Europe Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) Figure Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) Figure South America Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) Figure Middle East and Africa Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) Table North America Rheumatoid Arthritis (RA) Drugs Revenue by Countries (2013-2018) Table North America Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Countries (2013-2018) Figure North America Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Countries (2013-2018) Figure North America Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Countries in 2017 Figure USA Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) Figure Canada Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) Figure Mexico Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) Table Europe Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) by Countries (2013-2018) Figure Europe Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Countries (2013-2018) Figure Europe Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Countries in 2017 Figure Germany Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) Figure UK Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) Figure France Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) Figure Russia Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) Figure Italy Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) Table Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) by Countries (2013-2018) Figure Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Countries (2013-2018) Figure Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Countries in 2017 Figure China Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) Figure Japan Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) Figure Korea Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) Figure India Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) Figure Southeast Asia Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) Table South America Rheumatoid Arthritis (RA) Drugs Revenue by Countries (2013-2018) Table South America Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Countries (2013-2018) Figure South America Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Countries (2013-2018) Figure South America Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Countries in 2017 Figure Brazil Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) Figure Argentina Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) Figure Colombia Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) Table Middle East and Africa Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) by Countries (2013-2018) Table Middle East and Africa Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Countries in 2017 Figure Saudi Arabia Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) Figure UAE Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) Figure Egypt Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) Figure Nigeria Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) Figure South Africa Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2013-2018) Table Global Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) by Type (2013-2018) Table Global Rheumatoid Arthritis (RA) Drugs Revenue Share by Type (2013-2018) Figure Global Rheumatoid Arthritis (RA) Drugs Revenue Share by Type (2013-2018) Figure Global Rheumatoid Arthritis (RA) Drugs Revenue Share by Type in 2017 Table Global Rheumatoid Arthritis (RA) Drugs Revenue Forecast by Type (2018-2023) Figure Global Rheumatoid Arthritis (RA) Drugs Market Share Forecast by Type (2018-2023) Figure Global Oral Revenue Growth Rate (2013-2018) Figure Global Injection Revenue Growth Rate (2013-2018) Figure Global External Revenue Growth Rate (2013-2018) Table Global Rheumatoid Arthritis (RA) Drugs Revenue by Application (2013-2018) Table Global Rheumatoid Arthritis (RA) Drugs Revenue Share by Application (2013-2018) Figure Global Rheumatoid Arthritis (RA) Drugs Revenue Share by Application (2013-2018) Figure Global Rheumatoid Arthritis (RA) Drugs Revenue Share by Application in 2017 Table Global Rheumatoid Arthritis (RA) Drugs Revenue Forecast by Application (2018-2023) Figure Global Rheumatoid Arthritis (RA) Drugs Market Share Forecast by Application (2018-2023) Figure Global Medical Care Revenue Growth Rate (2013-2018) Figure Global Personal Care Revenue Growth Rate (2013-2018) Figure Global Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) and Growth Rate Forecast (2018 -2023) Table Global Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) Forecast by Regions (2018-2023) Figure Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share Forecast by Regions (2018-2023) Figure North America Rheumatoid Arthritis (RA) Drugs Revenue Market Forecast (2018-2023) Figure Europe Rheumatoid Arthritis (RA) Drugs Revenue Market Forecast (2018-2023) Figure Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue Market Forecast (2018-2023) Figure South America Rheumatoid Arthritis (RA) Drugs Revenue Market Forecast (2018-2023) Figure Middle East and Africa Rheumatoid Arthritis (RA) Drugs Revenue Market Forecast (2018-2023)

AbbVie Roche Johnson & Johnson Amgen, Inc. Pfizer Merck Bristol-Myers Squibb UCB GlaxoSmithKline Sanofi Abbott Laboratories Teva Pharmaceutical